Basic information of Hebei Shenwei Pharmaceutical Co., Ltd.

Shenwei Pharmaceutical Co., Ltd. is a young, open and energetic large-scale modern Chinese medicine industry group, one of the top 100 medicines in China and one of the top five proprietary Chinese medicines, and the largest pharmaceutical company with the largest market value on the Hong Kong Stock Exchange. Won hundreds of honorary titles such as the most growing independent brand enterprise in the industry, the May 1st Labor Medal, and the national advanced unit for implementing customer satisfaction project. As an industry model of modern Chinese medicine quality control, Shenwei Pharmaceutical has been praised by the State Administration of Pharmaceutical Products for many times and recommended by the central media for many times.

In 2002 and 20 10, "Shenwei" and "Five Blessingg" were successively recognized as well-known trademarks in China by the state. In 2003, Shenwei Pharmaceutical passed the national GMP certification in an all-round way; In 2004, it obtained the (IMS) certificate issued by the British Standards Institute (BSI), and took the lead in passing the quality management system (ISO900 1), environmental management system (ISO 1400 1) and occupational safety and health management system (OHSAS1800/KLOC). In 2006, it passed GMP certification of TGA in Australia. The seminar has been recognized by more than 20 PIC/S countries such as Britain, Germany and France.

The quality center of modern science and technology has passed the national laboratory certification. Shenwei Pharmaceutical has built the only high-tech industrialization demonstration project of advanced process integration and automatic control in the production process of traditional Chinese medicine preparations and the quality standardization demonstration project of traditional Chinese medicine injections in China. It has become a national demonstration base for high-tech industrialization of traditional Chinese medicine preparations and a national 863 achievement industrialization base. Shenwei Pharmaceutical focuses on the three fast-growing target markets of middle-aged and elderly people, children and antiviral drugs, focusing on the development of new dosage forms and new products of modern Chinese medicine, forming a powerful product portfolio featuring three dosage forms of modern Chinese medicine injections, modern Chinese medicine soft capsules and modern Chinese medicine granules.